Our group has examined health outcome measures used in AD, studied the appropriate use of systemic drugs in patients with moderate-to-severe AD, and devised video-based education to reduce AD severity.

We have conducted multiple studies using large databases examining the relationship between skin diseases and comorbidities, especially in the area of psoriasis. For example, we found that psoriasis patients have more difficult-to-control hypertension compared to non-psoriatic, hypertensive patients. We also found that psoriasis patients with diabetes have higher rates of microvascular and macrovascular complications compared to diabetic patients without psoriasis. Finally, we observed that psoriasis patients with longer duration of disease have a higher prevalence of angiographically confirmed coronary artery disease than patients without psoriasis.

We found that telehealth, especially teledermatology, has the potential to increase access to dermatological care. However, the delivery and reimbursement of teledermatology must be carefully considered for successful dissemination of this technology-enabled model. Novel models of teledermatology needs to focus on collaborative care of the patient by the specialist and the primary care provider.